Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

Recruiting now

Conditions studied: Colorectal Cancer

In brief

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Key facts

Study ID

NCT05950503

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

100

Starts

2023-07-10

Expected to finish

2027-06-07

Last updated by the study team

2025-09-02

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years;
• Histological diagnosis of colorectal cancer;
• Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
• At least one measurable liver lesion according to RECIST 1.1 criteria;
• Adequate organ and marrow function.

You may not qualify if…

• Age < 18 years;
• Inability to undergo MRI;
• Major contraindications to liver surgery;
• No written informed consent.

Where it is running

• Policlinico Agostino Gemelli — Roma, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.